{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:06:48Z","timestamp":1792048008109,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005335","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000}}],"reference-count":100,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005335.pub2","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T12:08:22Z","timestamp":1233662902000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Combined psychotherapy plus benzodiazepines for panic disorder"],"prefix":"10.1002","volume":"2010","author":[{"given":"Norio","family":"Watanabe","sequence":"first","affiliation":[{"name":"Nagoya City University Graduate School of Medical Sciences; Department of Psychiatry & Cognitive-Behavioral Medicine; Kawasumi 1 Mizuho-cho, Mizuho-ku Nagoya Aichi Japan 467-8601"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Churchill","sequence":"additional","affiliation":[{"name":"University of Bristol; Academic Unit of Psychiatry, Community Based Medicine; Cotham House, Cotham Hill Bristol Avon UK BS6 6JL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Nagoya City University Graduate School of Medical Sciences; Department of Psychiatry & Cognitive-Behavioral Medicine; Kawasumi 1 Mizuho-cho, Mizuho-ku Nagoya Aichi Japan 467-8601"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"10.1002\/14651858.CD005335.pub2-BIB0001|cit1","first-page":"91","article-title":"A comparison of th efficacy of alprazolam-XR plus cognitive-behavioral therapy versus cognitive-behavioral therapy plus placebo for acute treatment at three-month follow-up","author":"Auerbach","year":"1997","journal-title":"150th Annual Meeting of the American Psychiatric Association"},{"issue":"2","key":"10.1002\/14651858.CD005335.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004714-200104000-00003","article-title":"Absence of neuropsychologic deficits in patients receiving long-term treatement with alprazolam-XR for panic disorder","volume":"21","author":"Gladsjo","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD005335.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/archpsyc.1997.01830200078011","article-title":"Double-blindness procedures, rater blindness, and ratings of outcome. Observations from a controlled trial","volume":"54","author":"Basoglu","year":"1997","journal-title":"Archives of general psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD005335.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1192\/bjp.164.5.652","article-title":"Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse","volume":"164","author":"Basoglu","year":"1994","journal-title":"The British journal of psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD005335.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1192\/bjp.164.5.647","article-title":"Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure","volume":"164","author":"Basoglu","year":"1994","journal-title":"The British journal of psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005335.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-0327(94)90040-X","article-title":"Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure","volume":"30","author":"Basoglu","year":"1994","journal-title":"Journal of affective disorders"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0327(95)00053-4","article-title":"Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam","volume":"35","author":"Bond","year":"1995","journal-title":"Journal of affective disorders"},{"issue":"4","key":"10.1002\/14651858.CD005335.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1017\/S0033291700029056","article-title":"Memory functions, alprazolam and exposure therapy: a controlled longitudinal study of agoraphobia with panic disorder","volume":"24","author":"Curran","year":"1994","journal-title":"Psychological medicine"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S003329179800734X","article-title":"Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia\/panic patients","volume":"29","author":"Kilic","year":"1999","journal-title":"Psychological medicine"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1192\/bjp.163.6.835a","article-title":"Panic disorder with agoraphobia","volume":"163","author":"Klein","year":"1993","journal-title":"The British journal of psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1192\/bjp.162.6.795","article-title":"Drug treatment of panic disorder. Further comment","volume":"162","author":"Marks","year":"1993","journal-title":"The British journal of psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1192\/bjp.162.6.776","article-title":"Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto","volume":"162","author":"Marks","year":"1993","journal-title":"The British journal of psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005335.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1192\/bjp.165.1.79","article-title":"Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder","volume":"165","author":"O'Sullivan","year":"1994","journal-title":"The British journal of psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005335.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/026988119601000204","article-title":"Alprazolam withdrawal symptoms in agoraphobia with panic disorder: obsercations from a controlled Anglo-Canadian study","volume":"10","author":"O'Sullivan","year":"1996","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"788-9; discussi","DOI":"10.1192\/bjp.162.6.788","article-title":"Comment on the London\/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia","volume":"162","author":"Spiegel","year":"1993","journal-title":"The British journal of psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005335.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF02246023","article-title":"Changes in \"withdrawal symptoms\" following discontinuation of low-dose diazepam","volume":"125","author":"Hayward","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1002\/14651858.CD005335.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0005-7967(94)90113-9","article-title":"Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia","volume":"32","author":"Wardle","year":"1994","journal-title":"Behaviour research and therapy"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0005-7967(82)90140-1","article-title":"Exposure and communications training in the treatment of agoraphobia","volume":"20","author":"Chambless","year":"1982","journal-title":"Behaviour Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00464571","article-title":"Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study","volume":"77","author":"Chouinard","year":"1982","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1891\/0889-8391.5.3.199","article-title":"Models and treatment of panic: behavioural therapy of panic","volume":"5","author":"Craske","year":"1991","journal-title":"Journal of Cognitive Psychotherapy"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S1352465800010481","article-title":"Interactions between self-exposure and alprazolam in the treatment of agoraphobia without current panic: an exploratory study","volume":"21","author":"Echeburua","year":"1993","journal-title":"Behavioural and Cognitive Psychotherapy"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0033291700007510","article-title":"Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation","volume":"6","author":"Hafner","year":"1976","journal-title":"Psychological Medicine"},{"issue":"575","key":"10.1002\/14651858.CD005335.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1192\/bjp.123.4.463","article-title":"Arousal levels and attribution effects in diazepam-assisted flooding","volume":"123","author":"Johnston","year":"1973","journal-title":"The British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0024|cit24","first-page":"42","article-title":"A model of therapeutic action in panic disorders","volume":"14","author":"Lopez Alonso","year":"2000","journal-title":"The European Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD005335.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.150.10.1485","article-title":"Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder","volume":"150","author":"Otto","year":"1993","journal-title":"The American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0887-6185(95)00003-7","article-title":"Effects of alprazolam dose on the induction and habituation processes during behavioral panic induction treatment","volume":"9","author":"Riley","year":"1995","journal-title":"Journal of Anxiety Disorders"},{"issue":"6","key":"10.1002\/14651858.CD005335.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.151.6.876","article-title":"Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?","volume":"151","author":"Spiegel","year":"1994","journal-title":"The American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0005-7916(78)90032-0","article-title":"Flooding treatment of phobias: does chronic diazepam increase effectiveness?","volume":"9","author":"Whitehead","year":"1978","journal-title":"Journal of Behavior Therapy and Experimental Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005335.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1037\/0022-006X.72.4.625","article-title":"Effectiveness of cognitive--behavioral treatment for panic disorder versus treatment as usual in a managed care setting","volume":"72","author":"Addis","year":"2004","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0447.1991.tb03097.x","article-title":"Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.","volume":"365","author":"Andersch","year":"1991","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0031|cit31","first-page":"1","article-title":"Practice guideline for the treatment of patients with panic disorder","volume":"155 Supplement","author":"American Psychiatric Association","year":"1998","journal-title":"The American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0032|cit32","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision)","author":"American Psychiatric Association","year":"2000"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02193090","article-title":"What treatments do patients with panic disorder and agoraphobia get?","volume":"245","author":"Bandelow","year":"1995","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1002\/14651858.CD005335.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1192\/bjp.164.5.647","article-title":"Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure","volume":"164","author":"Basoglu","year":"1994","journal-title":"The British journal of psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0036|cit36","volume-title":"Depression: Causes and Treatment","author":"Beck","year":"1972"},{"issue":"6","key":"10.1002\/14651858.CD005335.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1176\/ajp.149.6.778","article-title":"A crossover study of focused cognitive therapy for panic disorder","volume":"149","author":"Beck","year":"1992","journal-title":"The American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0038|cit38","first-page":"91","article-title":"A cross over study of focussed cognitive therapy for panic disorder","volume":"39","author":"Bowen","year":"1994","journal-title":"The American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1037\/0022-006X.63.5.754","article-title":"Long-Term outcome in cognitive-behavioural treatment of panic disorder: clinical predictors and alternative strategies for assessment","volume":"63","author":"Brown","year":"1995","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0005-7894(86)80096-X","article-title":"Agoraphobia 8 years after behavioral treatment: a follow-up study with interview, self-report, and behavioral data","volume":"17","author":"Burns","year":"1986","journal-title":"Behavioral Therapy"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00127-002-0542-y","article-title":"12-month prevalence of panic disorder with or without agoraphobia in the Swedish general population","volume":"37","author":"Carlbring","year":"2002","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in treatment assignment in controlled clinical trials","volume":"1983","author":"Chalmers","year":"1983","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1037\/0022-006X.52.6.1090","article-title":"Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire","volume":"52","author":"Chambless","year":"1984","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0005-7967(85)90140-8","article-title":"The Mobility Inventory for Agoraphobia","volume":"23","author":"Chambless","journal-title":"Behaviour Research and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD005335.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1037\/0022-006X.67.4.583","article-title":"Brief cognitive therapy for panic disorder: a randomized controlled trial","volume":"67","author":"Clark","year":"1999","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/sim.4780080408","article-title":"How study design affects outcomes in comparisons of therapy. I: medical","volume":"9","author":"Coldiz","year":"1989","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0047|cit47","volume-title":"SCL-90-R: Manual-II","author":"Derogatis","year":"1983"},{"issue":"9","key":"10.1002\/14651858.CD005335.pub2-BIB0048|cit48","first-page":"458","article-title":"Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study","volume":"47","author":"Dunner","year":"1986","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1017\/S0033291701003592","article-title":"Long-term outcome of panic disorder with agoraphobia treated by exposure","volume":"31","author":"Fava","year":"2001","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ije\/31.1.72","article-title":"Can we individualize the Number Needed to Treat (NNT)? An empirical study of summary effect measures in meta-analyses","volume":"31","author":"Furukawa","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analyses","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0052|cit52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004364.pub2","article-title":"Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia","author":"Furukawa","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0053|cit53","first-page":"217","article-title":"ECDEU Assessment Manual for Psychopharmacology","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"The British Journal of Medical Psychology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"183-95","key":"10.1002\/14651858.CD005335.pub2-BIB0056|cit56","article-title":"Combined cognitive behavioral and time-limited alprazolam treatment of panic disorder","volume":"25","author":"Hegel","year":"1994","journal-title":"Behavior Therapy"},{"issue":"11","key":"10.1002\/14651858.CD005335.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0058|cit58","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch8","article-title":"Chapter 8: \u00a0Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1192\/bjp.178.4.331","article-title":"Self-exposure therapy for panic disorder with agoraphobia: randomised controlled study of external v. interoceptive self-exposure","volume":"178","author":"Ito","year":"2001","journal-title":"The British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD005335.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1037\/0022-006X.71.6.1068","article-title":"A comparison of delivery methods of cognitive-behavioral therapy for panic disorder: an international multicenter trial","volume":"71","author":"Kenardy","year":"2003","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archpsyc.55.9.801","article-title":"Lifetime Panic-Depression Comorbidity in the National Comorbidity Survey","volume":"55","author":"Kessler","year":"1998","journal-title":"Archives of Geneneral Pscyhiatry"},{"issue":"6","key":"10.1002\/14651858.CD005335.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Pevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0005-7967(79)90041-X","article-title":"Brief standard self-rating for phobic patients","volume":"17","author":"Marks","year":"1979","journal-title":"Behaviour Research and Therapy"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00004714-200206000-00010","article-title":"Duration of imipramine therapy and relapsein panic disorder with agoraphobia","volume":"22","author":"Mavissakalian","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","article-title":"The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","author":"McHorney","year":"1994","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2005.05.003","article-title":"A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia","volume":"88","author":"Mitte","year":"2005","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? [see comments]","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0069|cit69","volume-title":"A guide to Treatments that Work. 2nd edition","author":"Nathan","year":"2002"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/1047-2797(94)00112-7","article-title":"Risk of traffic accident injury after a prescription for a benzodiazepine","volume":"5","author":"Neutel","year":"1995","journal-title":"Annals of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD005335.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ageing\/25.4.273","article-title":"New evidence on benzodiazepine use and falls: the time factor","volume":"25","author":"Neutel","year":"1996","journal-title":"Age and Ageing"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/archpsyc.1984.01790140077009","article-title":"Diazepam and propranolol in panic disorder and agoraphobia","volume":"41","author":"Noyes","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD005335.pub2-BIB0073|cit73","first-page":"349","article-title":"Diazepam versus alprazolam for the treatment of panic disorder","volume":"57","author":"Noyes","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD005335.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0005-7967(97)00038-7","article-title":"Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?","volume":"35","author":"Oei","year":"1997","journal-title":"Behaviour Research and Therapy"},{"issue":"473-82","key":"10.1002\/14651858.CD005335.pub2-BIB0075|cit75","article-title":"Maintenance of remission following cognitive behavior therapy for panic disorder: possible deleterious effects of concurrent medication treatment","volume":"27","author":"Otto","year":"1996","journal-title":"Behaviour Research and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses.","volume":"116","author":"Oxman","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archpsyc.1988.01800290043006","article-title":"Alprazolam in panic disorder and agoraphobia: results grom a multicenter trial. III. Discontinuation effects","volume":"45","author":"Pecknold","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0078|cit78","volume-title":"Manual for the Anxiety Sensitivity Index","author":"Peterson","year":"1992"},{"issue":"2","key":"10.1002\/14651858.CD005335.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/anxi.3070010204","article-title":"Lactate-induced anxiety after imipramine and diazepam treatment","volume":"1","author":"Pohl","year":"1994","journal-title":"Anxiety"},{"issue":"6 Supplement 2","key":"10.1002\/14651858.CD005335.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/00004714-199812001-00004","article-title":"Panic disorder: long-term pharmacotherapy and discontinuation.","volume":"18","author":"Rickles","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1037\/0033-3204.30.1.125","article-title":"Observations on the cognitive behavioral treatment of panic disorder: impact of benzodiazepines","volume":"30","author":"Sanderson","year":"1993","journal-title":"Psychotherapy"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0165-0327(93)90101-O","article-title":"Affective Comorbidity in panic disorder: is there a bipolar connection?","volume":"28","author":"Savino","year":"1993","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1998.tb05973.x","article-title":"Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management","volume":"393","author":"Schweizer","year":"1998","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1176\/ajp.154.11.1571","article-title":"Multicenter collaborative panic disorder severity scale","volume":"154","author":"Shear","year":"1997","journal-title":"The American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"Suppl 3","author":"Sheehan","year":"1996","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0327(01)00359-7","article-title":"Longitudinal outcome with phramacotherapy in a naturalistic study of panic disorder","volume":"69","author":"Simon","year":"2002","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1002\/14651858.CD005335.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1176\/ajp.154.6.773","article-title":"Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials","volume":"154","author":"Spiegel","year":"1997","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD005335.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.psychres.2003.11.001","article-title":"Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choices","volume":"125","author":"Starcevic","year":"2004","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0005-7967(93)90026-Q","article-title":"Group cognitive-behavioral treatment of panic disorder","volume":"31","author":"Telch","year":"1993","journal-title":"Behaviour Research and Therapy"},{"issue":"5","key":"10.1002\/14651858.CD005335.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1037\/0022-006X.63.5.823","article-title":"Impact of cognitive-behavioral treatment on quality of life in panic disorder patients","volume":"63","author":"Telch","year":"1995","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2000-11221","article-title":"A prospective naturalisitic study of 326 panic-agoraphobic patients treated with antidepressants","volume":"33","author":"Toni","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005335.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005053-199602000-00015","article-title":"Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia","volume":"184","author":"Balkom","year":"1996","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1192\/bjp.156.2.163","article-title":"Behaviour therapy and benzodiazepines: allies or antagonists?","volume":"156","author":"Wardle","year":"1990","journal-title":"The British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJM198911023211801","article-title":"Suicidal ideation and Attempts in panic disorder and attacks","volume":"321","author":"Weissman","year":"1989","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005335.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archpsyc.1997.01830160021003","article-title":"The cross-national epidemiology of panic disorder","volume":"54","author":"Weissman","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0272-7358(97)00084-6","article-title":"Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?","volume":"18","author":"Westra","year":"1998","journal-title":"Clinical Psychology Review"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0887-6185(02)00091-9","article-title":"Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia","volume":"16","author":"Westra","year":"2002","journal-title":"Journal of Anxiety Disorders"},{"issue":"3","key":"10.1002\/14651858.CD005335.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0005-7967(95)00063-1","article-title":"Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability","volume":"34","author":"Williams","year":"1996","journal-title":"Behaviour Research and Therapy"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005335.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T11:17:49Z","timestamp":1763378269000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005335.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005335.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}